Kidney Cancer SPORE Administrative Core coordinating patient-focused research
Official title: DF/HCC Kidney Cancer Administrative Core
Funded at Beth Israel Deaconess Medical Center · NIH-11421795 · Data updated 2026-11-12
A broad kidney cancer research program at a major Boston center is coordinating science, funding, and patient-facing activities to speed advances and share findings.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 18, 2003 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $322,233 |
| NIH project number | 2P50CA101942-21A1 |
| Project ID | NIH-11421795 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with kidney cancer who may engage in research participation or contribute to program planning and dissemination activities.
✕Less likely to help
Patients not directly involved in the SPORE activities or administrative-linked patient outreach may see indirect benefits only.
What this research studies
This grant supports the Administrative Core that ensures all kidney cancer research components work together, with oversight of scientific, administrative, and fiscal activities. It emphasizes planning future research, fostering collaboration, and involving patients in research and treatment discussions. It also includes leadership by the SPORE Directors to monitor progress, support career development, and disseminate important results to the cancer community. The focus is on organizing seminars, retreats, and rapid communication of findings to advance patient care while managing resources responsibly. Overall, it aims to create a cohesive program that accelerates meaningful improvements for people affected by kidney cancer.
Why it matters
Potential benefit: If successful, patients may benefit from faster translation of research into new treatments and improved opportunities to participate in cutting-edge kidney cancer studies.
How similar studies have gone: Administrative cores in SPORE programs have previously demonstrated effective coordination and faster dissemination of research findings, though impact varies by program.
Where this research is happening
-
Beth Israel Deaconess Medical Center
Boston, United States Active
Researchers
- Principal investigator: Mcdermott, David — Beth Israel Deaconess Medical Center
- Study coordinator: Mcdermott, David
Related research
Other NIH-funded projects on the same topics.
-
Maximizing anti-tumor immune responses in kidney cancer
A cutting-edge program at UT Southwestern aims to speed up better immunotherapy options for kidney cancer by studying how to activate both innate and adaptive immune responses.
-
Kidney Cancer Career Enhancement Program (CEP) at DF/HCC
A career-boosting program supports junior investigators studying kidney cancer to help them advance in basic, translational, and clinical work.
-
Kidney Cancer Development Program at DF/HCC
A funded program at Dana-Farber/Brigham and Women’s Kidney Cancer Center supports new ideas from researchers to improve understanding and treatment of kidney cancer.
-
Personalized antigens for kidney cancer therapy
This grant explores identifying and targeting tumor-specific antigens in kidney cancer to develop more effective, personalized immunotherapies.
-
Optimizing Anti-PD1 Therapy for High-Risk and Metastatic Kidney Cancer
A large cancer research grant is testing how best to use anti-PD-1 therapy to help people with high-risk and metastatic kidney cancer live longer and with fewer side effects.
-
Targeting the HIF2 Pathway in Kidney Cancer
A cancer treatment program aims to see if a drug called belzutifan can help people with a specific kind of kidney cancer whose growth is driven by the HIF2 pathway.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.